HIV Tat and Rev (Composite Entity) (Tat/Rev)

The query "HIV Tat/Rev" is not a standard single molecular entity. Tat and Rev are distinct proteins with different functions and should be considered as separate targets for any structured annotation. HIV-1 Tat (trans-activator of transcription) is a small, ~14 kDa nuclear viral regulatory protein essential for efficient transcriptional elongation of the integrated viral genome. Tat binds the transactivation response (TAR) element in the HIV-1 5’ LTR and recruits the host positive transcription elongation factor b (P-TEFb), boosting processive viral gene expression. Tat also alters host gene expression, modulates apoptosis, and can be released to affect neighboring uninfected cells, contributing to HIV pathogenesis and immune dysfunction. HIV-1 Rev (regulator of expression of virion proteins) is an ~13 kDa RNA-binding viral protein that enables export of intron-containing HIV mRNAs from the nucleus to the cytoplasm, a process normally restricted in eukaryotic cells. Rev recognizes the Rev response element (RRE) in viral RNA through its arginine-rich motif, multimerizes, and utilizes its nuclear export signal to hijack host export machinery, resulting in production of structural proteins and assembly of new virions. Both Tat and Rev are nonstructural, early viral proteins, and are indispensable for HIV replication and the production of infectious virus. Because “HIV Tat/Rev” is not a single entity but shorthand for the coordinated activities of two distinct proteins, structured data annotation should capture them individually, and queries referencing both should be flagged as potentially ambiguous or non-standard.

Other names

Trans-activator proteinTat proteinHIV-1 TatRegulator protein RevRev proteinHIV-1 Rev

Tat: Drugs may block Tat binding to TAR RNA, inhibit its interaction with host transcription machinery, or disrupt Tat-mediated transactivation. Rev: Drugs may block Rev-RRE binding, interfere with multimerization, or disrupt nuclear export of viral RNAs.